Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2006 Jul;90(7):805-6.
doi: 10.1136/bjo.2006.093328.

Half dose verteporfin PDT for central serous chorioretinopathy

J M Stewart
Editorial

Half dose verteporfin PDT for central serous chorioretinopathy

J M Stewart. Br J Ophthalmol. 2006 Jul.

Abstract

Tailoring the therapy to the disease

PubMed Disclaimer

Comment on

References

    1. Chan W M, Lam D S C, Lai T Y Y.et al Choroidal vascular remodeling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003871453–1458. - PMC - PubMed
    1. Taban M, Boyer D S, Thomas E L.et al Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 20041371073–1080. - PubMed
    1. Yanuzzi L A, Slakter J S, Gross N E.et al Indocyanine green angiography‐guided photodynamic therapy for treatment of chronic central serous chorioretinopathy. Retina 200323288–298. - PubMed
    1. Piccolino F C, Eandi C M, Ventre L.et al Photodynamic therapy for chronic central serous chorioretinopathy. Retina 200323752–763. - PubMed
    1. Lai T Y Y, Chan W ‐ M, Li H.et al Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol 200690869–874. - PMC - PubMed

MeSH terms